Literature DB >> 35066614

RNF43 as a predictor of malignant transformation of pancreatic mucinous cystic neoplasm.

Kukiko Sakihama1,2, Yutaka Koga3, Takeo Yamamoto1,2, Yuki Shimada1,2, Yutaka Yamada1,2, Jun Kawata1,2, Koji Shindo2, Masafumi Nakamura2, Yoshinao Oda4.   

Abstract

Mucinous cystic neoplasm (MCN) of the pancreas rarely progresses to invasive carcinoma, but few studies have analyzed genomic alterations involved in its malignant transformation. The relationships of ring finger protein 43 (RNF43) mutations with cytological atypia, RNF43 protein expression, and Wnt signaling proteins in MCN remain unclear. This study included 106 MCN cases, classified into 89 low-grade dysplasia (LG), 9 high-grade dysplasia (HG), and 8 invasive carcinoma (INV). We analyzed HG/INV and LG lesions of 9 HG/INV cases and LG lesions of 9 LG cases using targeted sequencing and confirmed the protein expression of RNF43 and β-catenin. The frequency of RNF43 mutations was significantly higher in HG/INV cases than in LG cases. Furthermore, HG/INV lesions (56%) and LG lesions (33%) of HG/INV cases possessed RNF43 mutation, whereas no such mutation was detected in any LG cases. The expression of RNF43 was reduced in 71% of HG/INV cases and significantly correlated with histological grade and aberrant expression of β-catenin. In 3 of 5 RNF43-mutated cases, the expression of RNF43 was reduced, but there was no significant correlation between RNF43 mutation and protein expression. MCNs frequently harbored KRAS mutations, at rates of 100% in HG/INV lesions and 50% in LG lesions of HG/INV and LG cases. There was no significant difference in mutation frequency in LG lesions between HG/INV and LG cases. These results suggest that RNF43 mutations may be involved in and predictive of malignant transformation from an early stage of MCN.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  KRAS; Mucinous cystic neoplasm; Pancreas; RNF43

Mesh:

Substances:

Year:  2022        PMID: 35066614     DOI: 10.1007/s00428-022-03277-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  5 in total

1.  Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.

Authors:  Hideki Shibata; Nobuyuki Ohike; Tomoko Norose; Tomohide Isobe; Reika Suzuki; Hideyuki Imai; Akira Shiokawa; Takeshi Aoki; Masahiko Murakami; Hiroki Mizukami; Jun-Ichi Tanaka; Masafumi Takimoto
Journal:  Anticancer Res       Date:  2017-12       Impact factor: 2.480

2.  A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer.

Authors:  Ryuichiro Yagyu; Yoichi Furukawa; Yu-Min Lin; Takashi Shimokawa; Takehira Yamamura; Yusuke Nakamura
Journal:  Int J Oncol       Date:  2004-11       Impact factor: 5.650

3.  How does intestinal-type intraductal papillary mucinous neoplasm emerge? CDX2 plays a critical role in the process of intestinal differentiation and progression.

Authors:  Yuko Omori; Yusuke Ono; Toshikazu Kobayashi; Fuyuhiko Motoi; Hidenori Karasaki; Yusuke Mizukami; Naohiko Makino; Yoshiyuki Ueno; Michiaki Unno; Toru Furukawa
Journal:  Virchows Arch       Date:  2020-04-15       Impact factor: 4.064

4.  A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.

Authors:  Tadasuke Tsukiyama; Juqi Zou; Jihoon Kim; Shohei Ogamino; Yuki Shino; Takamasa Masuda; Alessandra Merenda; Masaki Matsumoto; Yoichiro Fujioka; Tomonori Hirose; Sayuri Terai; Hidehisa Takahashi; Tohru Ishitani; Keiichi I Nakayama; Yusuke Ohba; Bon-Kyoung Koo; Shigetsugu Hatakeyama
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

5.  Genomic characterization of malignant progression in neoplastic pancreatic cysts.

Authors:  Michaël Noë; Noushin Niknafs; Catherine G Fischer; Wenzel M Hackeng; Violeta Beleva Guthrie; Waki Hosoda; Marija Debeljak; Eniko Papp; Vilmos Adleff; James R White; Claudio Luchini; Antonio Pea; Aldo Scarpa; Giovanni Butturini; Giuseppe Zamboni; Paola Castelli; Seung-Mo Hong; Shinichi Yachida; Nobuyoshi Hiraoka; Anthony J Gill; Jaswinder S Samra; G Johan A Offerhaus; Anne Hoorens; Joanne Verheij; Casper Jansen; N Volkan Adsay; Wei Jiang; Jordan Winter; Jorge Albores-Saavedra; Benoit Terris; Elizabeth D Thompson; Nicholas J Roberts; Ralph H Hruban; Rachel Karchin; Robert B Scharpf; Lodewijk A A Brosens; Victor E Velculescu; Laura D Wood
Journal:  Nat Commun       Date:  2020-08-14       Impact factor: 17.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.